Skip to main content

Peer Review reports

From: TRIBE-2: a phase III, randomized, open-label, strategy trial in unresectable metastatic colorectal cancer patients by the GONO group

Original Submission
24 Nov 2015 Submitted Original manuscript
27 Apr 2016 Author responded Author comments - Chiara Cremolini
Resubmission - Version 2
27 Apr 2016 Submitted Manuscript version 2
3 Dec 2016 Reviewed Reviewer Report - Michael Overman
18 Dec 2016 Reviewed Reviewer Report - Ryan Nipp
10 Feb 2017 Author responded Author comments - Chiara Cremolini
Resubmission - Version 3
10 Feb 2017 Submitted Manuscript version 3
28 Apr 2017 Reviewed Reviewer Report - Feng Gao
8 May 2017 Author responded Author comments - Chiara Cremolini
Resubmission - Version 4
8 May 2017 Submitted Manuscript version 4
Publishing
15 May 2017 Editorially accepted
9 Jun 2017 Article published 10.1186/s12885-017-3360-z

You can find further information about peer review here.

Back to article page